Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Liver Fibrosis and Cirrhosis in Patients With Non-Alcoholic Fatty Liver With and Without History of Cholecystectomy: A Pilot Study Publisher



Parsi A1 ; Hajiani E1 ; Sadani S2 ; Hashemi SJ1 ; Seyedian SS1 ; Alimadadi M1 ; Ghanbari R3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Alimentary Tract Research Center, Clinical Sciences Research Institute, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  2. 2. Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
  3. 3. Gene Therapy Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Middle East Journal of Digestive Diseases Published:2024


Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in the world. Previous studies revealed that cholecystectomy may be considered a risk factor for the development of NAFLD. The aim of this study was to compare the amount of liver fibrosis, determined by elastography, between patients with NAFLD with and without a history of cholecystectomy. Methods: In this descriptive-analytical cross-sectional study, 50 patients with NAFLD were divided into two groups: one with a history of cholecystectomy and the other without. No significant differences were found between these two groups in terms of age or sex distribution. Liver fibrosis was measured for all patients using an elastography imaging system. Subsequently, the data related to liver fibrosis, along with the demographic information of the patients, were statistically analyzed using SPSS software version 22. Results: The mean elastography score in all patients was 10.66±12.18 kPa (the elasticity scale ranging from 3.80 to 66.40 kPa). The group with a history of cholecystectomy had a significantly higher mean elastography score (13.39±16.20 kPa) compared with the group without cholecystectomy (7.93±4.99 kPa) (P=0.02). Additionally, there was a significant positive correlation between body mass index (BMI) and the mean elastography score in the group of patients with a history of cholecystectomy. Conclusion: The mean elastography score of patients with NAFLD with a history of cholecystectomy was approximately twice as high as that of non-cholecystectomy patients. © 2024 The Author(s).
Related Docs
View other Related Docs
1. Flaxseed Supplementation in Non-Alcoholic Fatty Liver Disease: A Pilot Randomized, Open Labeled, Controlled Study, International Journal of Food Sciences and Nutrition (2016)
2. Effect of a Moderately Carbohydrate-Restricted Diet on Liver Enzymes, Steatosis and Fibrosis in Normal-Weight Individuals With Non-Alcoholic Fatty Liver Disease: Study Protocol for a Parallel Randomised Controlled Clinical Trial, BMJ Open (2023)
3. Synbiotic Supplementation in Lean Patients With Non-Alcoholic Fatty Liver Disease: A Pilot, Randomised, Double-Blind, Placebo-Controlled, Clinical Trial, British Journal of Nutrition (2017)
4. Curcumin and Inflammation in Non-Alcoholic Fatty Liver Disease: A Randomized, Placebo Controlled Clinical Trial, BMC Gastroenterology (2019)
5. Transient Elastography in Methotrexate Administered Patients, Hepatitis Monthly (2017)
6. Dietary Supplements and Pediatric Non-Alcoholic Fatty Liver Disease: Present and the Future, World Journal of Hepatology (2015)
7. Incidence of Symptomatic Cholelithiasis Following Laparoscopic Roux-En-Y Gastric Bypass Is Comparable to Laparoscopic Sleeve Gastrectomy: A Cohort Study, Digestive Diseases and Sciences (2022)
8. Abdominal Ultrasound Combined With Laboratory Tests As a Reliable, Easily Accessible and Cost-Effective Way of Assessing the Stages of Liver Fibrosis and Cirrhosis, Archives of Iranian Medicine (2022)
Experts (# of related papers)
View all Related Experts
Hossein Poustchi (3)
Reza Malekzadeh (1)
Other Related Docs
9. The Role of Moderate- and High-Intensity Supervised Aerobic Training in Reducing Steatosis and Hepatic Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease; a Randomized Controlled Trial, Gastroenterology and Hepatology from Bed to Bench (2023)